BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11339539)

  • 1. The current status of live attenuated varicella vaccine.
    Gershon AA
    Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
    Gershon AA
    J Infect; 2017 Jun; 74 Suppl 1(Suppl 1):S27-S33. PubMed ID: 28646959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
    Gershon AA; Gershon MD; Shapiro ED
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
    Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
    Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella Virus Vaccination in the United States.
    Shaw J; Gershon AA
    Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-attenuated varicella vaccine.
    Gershon AA
    Infect Dis Clin North Am; 2001 Mar; 15(1):65-81, viii. PubMed ID: 11301823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella vaccine: the American experience.
    Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
    J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination to prevent varicella and shingles.
    Breuer J
    J Clin Pathol; 2001 Oct; 54(10):743-7. PubMed ID: 11577118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular studies of the Oka varicella vaccine.
    Quinlivan M; Breuer J; Schmid DS
    Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with live-attenuated varicella-zoster vaccines.
    LaRussa P
    Contrib Microbiol; 1999; 3():173-92. PubMed ID: 10599530
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing varicella-zoster disease.
    Hambleton S; Gershon AA
    Clin Microbiol Rev; 2005 Jan; 18(1):70-80. PubMed ID: 15653819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
    N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.